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L A B O R A T O R Y I N V E S T I G A T I O N
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Abstract
Background: During early treatment of haemorrhagic shock, cerebral perfusion pressure can be restored by small-
volume resuscitation with vasopressors. Whether this therapy is improved with additional fluid remains unknown. We
assessed the value of terlipressin and lactated Ringer’s solution (LR) on the early recovery of the microcirculation, tissue
oxygenation, and mitochondrial and electrophysiological function in the rat cerebral cortex.
Methods: Animals treated with LR replacing three times (3LR) the volume bled (n¼26), terlipressin (n¼27), terlipressin
plus 1LR (n¼26), 2LR (n¼16), or 3LR (n¼15) were compared with untreated (n¼36) and sham-operated rats (n¼17) rats.
In vivo confocal microscopy was used to assess cortical capillary perfusion, changes in tissue oxygen concentration, and
mitochondrial membrane potential and redox state. Electrophysiological function was assessed by cortical somato-
sensory evoked potentials, spinal cord dorsum potential, and peripheral electromyography.
Results: Comparedwith sham, haemorrhagic shock reduced themean (standard deviation) area of perfused vessels [82% (SD
10%) vs 38% (12%); P<0.001] and impaired oxygen concentration,mitochondrial redox state [99% (4%) vs 59% (15%) of baseline;
P<0.001], andsomatosensoryevokedpotentials [97%(13%)vs27% (19%)ofbaseline].Administrationof terlipressinplus1LRor
2LR was able to recover these measures, but terlipressin plus 3LR or 3LR alone were not as effective. Spinal cord dorsum
potential was preserved in all groups, but no therapy protected electromyographic function.
Conclusions: Resuscitation from haemorrhagic shock using terlipressin with small-volume LR was superior to high-
volume LR, with regard to cerebral microcirculation, and mitochondrial and electrophysiological function.
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Laboratory Investigation
Haemorrhage remains a major cause of early death, ac-
counting for 30e40% of trauma mortality, with 33e56% of
deaths occurring before arrival at hospital.1 Life-threatening
loss of blood volume causes circulatory collapse.2 The conse-
quent impairment in oxygen supply to the brain3 may cause
neurological sequelae, most notably altered mentation
(including loss of consciousness), seizures, and ischaemic
stroke.2,4,5 The major mechanism is considered to be a cellular
energy crisis arising from tissue hypoxia.3,6,7 In addition to a
decrease in the cerebral macrocirculation, studies using ani-
mal models of haemorrhagic shock suggest impaired micro-
circulation8 and mitochondrial insufficiency.9 As cell damage
potentially starts at the onset of the haemodynamic decom-
pensation,6,7,10,11 blood supply to the brain must be restored
rapidly. However, the optimal method for resuscitation is not
established. Standard teaching is to restore adequate volaemia
before commencing vasopressor agents. However, despite
early fluid resuscitation to restore oxygen delivery to the tis-
sues, cerebral perfusion pressure and oxygenation may fail to
recover, especially if there is a persisting loss of vascular
tone.3,12
Vasopressors can reduce the volume of crystalloid required
to recover blood pressure after haemorrhagic shock and can
rapidly recover cerebral perfusion pressure during prehospital
care.3,13 Terlipressin, a synthetic analogue of vasopressin, has
been proposed for the treatment of haemorrhagic shock,14,15
and compared with vasopressin, it is longer acting and has
higher selectivity for the vasopressin V1 receptor.
15,16 Although
studies in models of haemorrhage have demonstrated that
terlipressin can improve cerebral perfusion pressure and tis-
sue oxygenation,12,17 the efficacy in protecting brain micro-
circulatory, mitochondrial, and electrophysiological function
is unknown. We therefore used confocal imaging to study the
circulation and metabolic state of the brain during shock
in vivo, and in real time. We postulated that small-volume
resuscitation with terlipressin would be superior to more
aggressive fluid replacement therapy in protecting mitochon-
drial and electrophysiological function, and perfused vessel
density, in a rodent model of haemorrhagic shock.
Methods
Experiments adhered to the Home Office (UK) 1986 Scientific
Procedures Act and European Directive 2010/63/EU and results
are reported according to relevant aspects of the Animal
Research: Reporting of In Vivo Experiments (ARRIVE) guide-
lines, with University College London animal Ethics Commit-
tee approval.
Rats (male, in-house, Sprague Dawley, ~150 g) were housed
in groups of five in pathogen free cages with a 12 h light/dark
cycle at 22C with standard rat pellets available ad libitum. Rats
were anaesthetised without recovery throughout the experi-
ments using isoflurane delivered via a vaporizer (induction 5%
in an induction cage, maintenance 1.5e2% via nose cone; Iso-
Flo, Abbott Labs, Maidenhead, UK) while spontaneously
breathing room air. Adequacy of anaesthesia was assessed by
ensuring the absence of withdrawal reflex after paw and ear
pinch, and bymonitoring the values of heart rate,meanarterial
pressure (MAP), and respiratory rate to noxious stimulation.
Rectal temperature (36e37oC; underblanket, Harvard Appa-
ratus, Cambridge, UK), direct MAP (left femoral artery con-
nected to a pressure transducer; World Precision Instruments,
Hitchin, UK), respiratory rate, and end-tidal carbon dioxide
(ETCO2; via orotracheal intubation, Microcap, Oridion, Need-
ham,MA,USA)were continuouslymonitored. The femoral vein
was cannulated for fluid and drug administration. A crani-
otomy ~8 mm in diameter (centred at bregma 2 mm, lateral
2.5mm)was performed over the left somatosensory cortex and
the animals either imaged using in vivo confocalmicroscopy, or
assessed electrophysiologically, for the rest of the experiment.
In vivo confocal microscopy
The skull was fixed to a custom-made titanium bar using dental
cement (Contemporary Ortho-Jet Powder, Lang Dental
Manufacturing Co., Wheeling, IL, USA) mixed with cyanoa-
crylate glue. The durawas removed, and platinum(II)-5,10,15,20-
tetrakis(2,3,4,5,6-pentafluorophenyl)porphyrin (PtPFPP)-based
phosphorescent oxygen-sensitive microbeads (Luxcel Bio-
sciences, Cork, Ireland) applied to the cortex. The craniotomy
was thensealedwitha glass coverslipandpetroleumjelly. Time-
lapse fluorescence images were acquired with a laser-scanning
confocal microscope (512 by 512 pixels, optical slice 37.1 mm;
LSM 5 Pascal, Zeiss, Jena, Germany) to assess mitochondrial
redox state by imaging endogenous flavoprotein fluorescence
(excitation: 488nm; emission: 505e570nm), andchanges in local
oxygen concentration (ex: 543 nm; em: 650 nm). At termination,
i.v. fluorescein isothiocyanate-dextran 70 kDA (FITC-dextran;
0.5 mg i.v.; ex: 488 nm; em: 505e570 nm; Sigma-Aldrich, Poole,
UK) and topical tetramethylrhodamine methyl ester (TMRM; 1
mM; ex: 543 nm; em: 585nm; T-668,Molecular Probes, Invitrogen,
Paisley,UK)were imaged toestablishperfusedvesseldensityand
mitochondrial membrane potential, respectively. Images were
processed using Fiji/Image J 1.48v (NIH, Bethesda, MD, USA).
Electrophysiology
The right tibial nerve was stimulated (DS2, Digitimer, Welwyn
Garden City, UK) percutaneously at the ankle (10 Hz, twice
supramaximal), with recording electrodes at the vertebral
level T10/T11, and on the cortical dura (2 mm from bregma,
2.5 mm from midline), with reference electrodes on nearby
inactive tissue. Another recording electrode was placed over
the ipsilateral metatarsal musculature, with a reference elec-
trode in the third digit. The ground electrode was inserted
under the lumbar skin. Recordings of the somatosensory
evoked potentials, cord dorsum potentials, and electromyo-
graphic signals were amplified (Neurolog System, Digitimer),
observed on an oscilloscope (Sigma 60, Nicolet, Madison, WI,
USA), and stored as averaged (n¼20) compound action poten-
tials. They weremonitored asmeasures of cortical, spinal, and
muscular function, respectively.
Editor’s key points
 Haemorrhage is the cause of up to 40% of deaths after
trauma.
 Early small volume resuscitation with terlipressin can
restore cerebral perfusion after haemorrhagic shock.
 The effect of additional fluid is unclear.
 In an experimental haemorrhage model in rats, resus-
citation with low but not high volume fluids plus terli-
pressin restored cerebral microcirculation and
mitochondrial and electrophysiological function.
 Optimum restoration of perfusion after haemorrhage is
likely to reduce morbidity and mortality.
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Study design
After instrumentation, repeated administrations of 1.5 ml i.v.
fluid challenges were given over 10 s every 5 min to ensure
normovolaemia at baseline, until MAP failed to increase
>10%.18 Animals were allowed to stabilize for 20 min before
randomization envelopes were opened with allocation into
one of the seven following groups: [i] not subjected to hae-
morrhagic shock (Sham; n¼17); [ii] subjected to haemorrhagic
shock, but untreated (Shock; n¼36); [iii] lactated Ringer’s
solution (LR) given at three times the volume of blood with-
drawn (3LR; aggressive fluid resuscitation: n¼26); [iv] bolus of
10 mg 100 g1 of terlipressin alone (n¼26), or combined with LR
in low volumes of [v] one (Terliþ1LR; n¼26) or [vi] two times
(Terliþ2LR; n¼26) the volume of blood withdrawn; or [vii]
combined with LR in a high volume of three times (Terliþ3LR;
aggressive fluid resuscitation; n¼26) the volume of blood
withdrawn. The dose of terlipressin was titrated in a pilot
study, starting from a dose previously described.14
Haemorrhagic shock was achieved by removing blood from
the arterial line, targeting a MAP of 40 mm Hg, maintained for
30 min by withdrawing or re-infusing blood when necessary,
before treatment.
Data were recorded at baseline, after 30 min with MAP of
40mmHg (shock), and at 5, 60, and 120min (T5, T60, and T120)
after treatment. After 150 min all surviving rats were culled
under 5% isoflurane anaesthesia.
Statistical analysis
The sample size was calculated in preliminary experiments
using a power analysis that indicated a minimum of 26 rats/
group was required for a 95% chance (with 5% risk) to detect a
difference between groups, of 60%, 40%, and 46% in the cortical
somatosensory evoked potentials (n¼6/group), mitochondrial
redox state (n¼10 rats/group), and changes in tissue oxygen
concentration (n¼10 rats/group), respectively, considering a
Table 1 Mean bodyweight, mean estimated blood volume
withdrawn, and mean time until death after shock. EBV,
estimated blood volume
Bodyweight
(g)
Blood
withdrawn
(%EBV)
Time of
death after
shock (min)
Sham 162.2 (34.7) e e
Shock 164.0 (40.4) 39.3 (7.1) 30 (22)
3LR 163.6 (24.8) 38.2 (8.6) 68 (25)
Terlipressin 162.9 (24.8) 37.8 (8.2) 52 (21)
Terlipressin þ 1LR 148.5 (15.7) 43.6 (6.9) 72 (27)*
Terlipressin þ 2LR 160.7 (36.9) 42.8 (6.7) 8
Terlipressin þ 3LR 160.6 (26.3) 43.2 (11.4) 44 (32)
* vs untreated Shock group P < 0.05
Fig 1. KaplaneMeier curve and changes in mean arterial pressure, respiratory rate, and end-tidal carbon dioxide induced by haemorrhagic
shock, and treatment with lactated Ringer’s solution (LR), terlipressin, and combined treatments of LR plus terlipressin. *vs Sham (at least
P<0.05); þ vs untreated Shock group (at least P<0.05).
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standard deviation (SD) of 8%, 15%, and 5%, respectively.
Endogenous flavoprotein fluorescence was analysed by
determining the ratio between the mean intensity of areas
adjacent to veins and arteries (perivenular:periarterial ra-
tio).19,20 The mean phosphorescence of the oxygen-sensitive
beads was analysed by selecting up to six beads representing
proximity to different vascular regions (the beads distribute
randomly). The emission signals of flavoproteins and oxygen-
sensitive beads analysed at each time-point were compared
with their corresponding emission signal at baseline. The
TMRM images were analysed 150min after shock, as described
for flavoproteins. The FITC-dextran fluorescencewas analysed
at 120 min after shock by determining the number of vessels
crossing three equidistant horizontal and vertical lines,
divided by the total length of the lines, and the area occupied
by fluorescent vessels above a threshold brightness. In the
electrophysiological recordings, the measurements at each
time-point were compared with the measurement at baseline.
Data were assessed for normality using the Kolmogor-
oveSmirnov test and were compared within and between
groups using repeated measure two-way analysis of variance
followed by Tukey’s post hoc testing (GraphPad Prism 5.03,
GraphPad Software Inc., La Jolla, CA, USA). The ‘last observa-
tion carried forward’ method was used when animals died
before the end of the study. Pearson’s coefficient was calcu-
lated to assess correlation between variables. A 0e40 scoring
system was calculated for each variable according to the per-
centage difference at T120/T150 compared with baseline/
sham: (0) for 0e20%, (1) for 21e40%, (2) for 41e60%, (3) for
61e80%, and (4) for 81e100%. The sum of the scores (0¼worst,
40¼best) was calculated to compare the effectiveness of each
treatment. Data are presented as mean and SD. Statistical sig-
nificance was P<0.05.
Results
Bleeding and survival
Ten rats from the Shock group were not included in the sta-
tistical analysis because they were used to generate the data
upon which to base the power calculation. Only a single bolus
of 1.5 ml fluid challenge was necessary in all rats to ensure
normovolaemia at baseline. Removal of approximately 40%
(approximately 4 ml) of the estimated blood volume (EBV) of
each rat [EBV (ml)¼0.06  body weight (g)þ0.77]21 (approxi-
mately 10 ml) was necessary to induce haemorrhagic shock as
defined by a MAP <40 mm Hg (Table 1). Most animals died
under anaesthesia when not treated after shock (P<0.001
Shock vs Sham; Fig. 1). Survival was higher in all treated
groups; the most effective treatment was Terliþ2LR (one
death; P<0.001 vs Shock).
Cardiorespiratory variables
Haemorrhagic shock caused a decrease in respiratory rate,
ETCO2, and MAP in all groups compared with Sham (P<0.001;
Fig. 1). This cardiorespiratory impairment did not recover at
any time in the Shock group. MAP was significantly higher at
T120 in all treated groups (P<0.001 vs Shock), although it
remained lower compared with Sham (P<0.001). The respira-
tory rate was restored by all treatments at T120. However, the
Fig 2. Changes in phosphorescence of oxygen-sensitive microbeads according to their location relative to the veins and arteries throughout
the study. * vs Sham of the same time-point (at least P<0.05); þ vs untreated Shock group of the same time-point (at least P<0.05). LR,
lactated Ringer’s solution.
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improvement in ETCO2 was lower than in Sham, although
higher than in Shock (P<0.001; Fig. 1).
Cortical tissue oxygenation
Haemorrhagic shock caused a significant decrease in tissue
oxygenation near veins at T60 and T120 in the untreated Shock
group compared with Sham (P<0.05; Fig. 2). At these same
time-points, the perivenular tissue oxygenation was signifi-
cantly higher after all treatments (P<0.05 vs Shock). Oxygen-
ation near arteries was maintained throughout.
Cerebral vascular density
The induction of haemorrhagic shock resulted in a significant
decrease in both the density [0.05 (SD 0.01) vs 0.17 (0.01) n mm2
for Sham, P<0.001] and percentage area of perfused vessels
[38% (12%) vs 82% (10%) for Sham, P<0.001] at T120 (Fig. 3).
Treatment with terlipressin and Terliþ2LR improved both
density and the percentage area of perfused vessels [0.14 (0.02)
and 0.14 (0.02) n mm2, P<0.001 vs Shock; 66% (14%) and 73%
(9%), P<0.001 vs Shock, respectively] achieving results that
were similar to Sham (Fig. 3). The other treatments were either
inferior to Sham (3LR and Terliþ1LR), or no better than un-
treated animals (Terliþ3LR).
Cerebral mitochondrial redox potential
In all groups, haemorrhagic shock caused a significant
decrease in flavoprotein fluorescence (i.e. increased reduced
state) adjacent to veins, but fluorescence persisted in a ‘halo’
around arteries (Fig. 4A), reflected by a reduction in the peri-
venular:periarterial fluorescence ratio (P<0.05; Fig. 4B). In the
Shock group, the ratio was lower at T120 compared with Sham
[59% (16%) vs 99% (4%) of baseline; P<0.001; Fig. 4B]. All treat-
ments were effective in increasing the fluorescence around
veins at T5. At study end, administration of 3LR [73% (20%) of
baseline; P<0.001] and Terliþ3LR [74% (18%) of baseline;
P<0.001] resulted in a lower perivenular:periarterial flavopro-
tein ratio compared with Sham, although higher than in Shock
(P<0.05). At T120, animals treated with Terli, Terliþ1LR and
Terliþ2LR showed ratios not significantly different to Sham
[87% (20%), 82% (20%), and 92% (15%) of baseline, respectively],
but higher than Shock (P<0.001) (Fig. 4).
Fig 3. Vasculature of the cerebral cortex assessed by fluorescein isothiocyanate (FITC)-dextran after 120 min of haemorrhagic shock. (A)
Total perfused vessel density shows quantity of blood vessels with flow. (B) Representative in vivo confocal images of the cortical
vasculature. (C) Area fraction of blood vessels representing relative area covered by FITC-dextran fluorescence. Notably fewer vessels in
untreated Shock, 3LR and Terliþ3LR groups than Sham. Images of rats receiving Terli and Terliþ2LR show no difference to Sham. * vs Sham
(at least P<0.05); þ vs untreated Shock group (at least P<0.05). LR, lactated Ringer’s solution.
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Cortical mitochondrial membrane potential
Mitochondrial membrane potential, indicated by TMRM fluo-
rescence (Fig. 5), revealed that most mitochondria were
depolarized (non-functional) after haemorrhagic shock. Only
the mitochondria located near arteries remained polarized,
resulting in arterial ‘halos’ similar to those observed with
flavoproteins. At 150 min after shock the perivenular:per-
iarterial ratio was worse in the Shock group [(0.28 (0.08);
P<0.001), 3LR (0.39 (0.13); P<0.001)], and Terliþ3LR [0.34 (0.01);
P<0.001], compared with Sham [0.97 (0.09)]. No significant
differences in the perivenular:periarterial TMRM ratio were
observed in the Terli [0.98 (0.31)], Terliþ1LR [0.76 (0.22)], and
Fig 4. Endogenous flavoprotein fluorescence induced by haemorrhagic shock and the effect of different treatments. (A) Representative
in vivo confocal images of rat cerebral cortex showing fluorescence of oxidized endogenous flavoprotein (green). Uniform fluorescence is
seen before haemorrhagic shock, but lost except for a ‘halo’ around arteries after shock. Some recovery of fluorescence after treatment is
seen at 5 min. At 120 min, fluorescence persists only in the Terli and Terliþ2LR groups. (B) Changes in the perivenular:periarterial ratio of
the endogenous flavoprotein fluorescence. * vs Sham (at least P<0.05); þ vs untreated Shock group (at least P<0.05). LR, lactated Ringer’s
solution.
6 - Ida et al.
Terliþ2LR [0.71 (0.04)] groups compared with Sham; values
were also better than in Shock (all P<0.001).
Electrophysiological function
All bled groups had decreased cortical function to approxi-
mately a third of baseline at shock (P<0.001 vs Sham). At T120,
cortical function decreased further to 27% (19%) of baseline in
Shock (Fig. 6); aggressive fluid (Terliþ3LR and 3LR) groups were
not significantly better than no treatment. The Terliþ1LR [73%
(32%) of baseline] and Terliþ2LR [95% (30%) of baseline] groups
were indistinguishable from Sham [97% (13%) from baseline],
and higher than in Shock (P<0.001) at T120. A decrease was
seen in peak-to-peak muscular function amplitude (P<0.001);
no treatments restored this to baseline values (Fig. 6). In the
Terliþ1LR (P<0.05) and Terliþ2LR (P<0.001) groups, the peak-
to-peak amplitude was greater at T120 compared with
Shock. The amplitude of the cord dorsum potential (Fig. 6) and
the peak latency of all potentials did not change significantly
in any group throughout the study (Table 2).
Correlations and scores for effectiveness of the
treatments
A positive correlation was seen between the decrease in MAP,
and changes in flavoprotein (r2¼0.84, P¼0.0006) and TMRM
signals (r2¼0.57, P¼0.0484), total perfused vessel density
(r2¼0.69, P¼0.0055), area fraction of perfused vessels (r2¼0.78,
P¼0.0019), and changes in cortical function (r2¼0.72, P¼0.0032),
at T120. At T120, the changes in fluorescence of the peri-
venular oxygen-sensitive microbeads showed a weak but
significant correlation with MAP (r2¼0.54; P¼0.0185), and with
changes in flavoprotein fluorescence (r2¼0.60; P¼0.0235) and
periarterial oxygen-sensitive microbeads (r2¼0.63; P¼0.0187).
In addition, changes in fraction of perfused vessels were
correlated with changes in flavoprotein fluorescence (r2¼0.90,
P¼0.0003), TMRM signals (r2¼0.89, P¼0.0172), and somatosen-
sory evoked potentials (r2¼0.82, P¼0.0018).
The Terliþ2LR (score of 33), Terliþ1LR (score of 27), and
Terli (score of 27) were the most effective treatments to
improve the variables assessed. Scores of effectiveness were
40 in Sham, 21 in 3LR, 20 in Terliþ3LR, and 11 in Shock.
Discussion
We describe the consequences of different resuscitation regi-
mens immediately after haemorrhagic shock, focusing on the
vasculature, oxygenation, and function of the nervous system.
Although the cerebral cortex is profoundly affected by hae-
morrhagic shock, with a dramatic reduction in perfusion of
the smaller vessels accompanied by loss of mitochondrial
function, it is nonetheless possible to restore perfusion,
mitochondrial, and neurological function by the timely
administration of effective therapy.
All treatments improved survival within the time course of
the study. Whilst administration of terlipressin was generally
associated with improvement in the measured variables, the
combination of terlipressin and aggressive fluid (i.e. Terliþ3LR)
was not. Whether this is because of negative cardiovascular
effects and/or other causes remains uncertain. If the ampli-
tude of the cortical evoked potential is taken as the benchmark
of a good outcome, this was optimally achieved by Terliþ2LR,
Fig 5. Graph and representative confocal in vivo images showing mitochondrial membrane potential in the cerebral cortex of rats at
150 min after haemorrhagic shock. In the untreated Shock group many mitochondria are depolarized, only mitochondria near arteries
remain polarized, resulting in periarterial tetramethylrhodamine methyl ester (TMRM) ‘halos’. A similar pattern of periarterial halos is
seen in rats treated with 3LR and Terliþ3LR, though polarized mitochondria were more widely distributed in rats treated with Terli,
Terliþ1LR and Terliþ2LR and the distribution is not significantly different to Sham. * vs Sham (at least P<0.05); þ vs untreated Shock group
(at least P<0.05). LR, lactated Ringer’s solution.
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and associated with a better mitochondrial membrane po-
tential (required for ATP production) and well-perfused blood
vessels. Mitochondrial and neuronal dysfunction were found
to correlate with impaired capillary perfusion, illuminating an
earlier discrepancy described between perfusion and total
cerebral flow.8
Of note, we found that mitochondrial function was selec-
tively preserved in cortical tissue surrounding arterioles,
which reveals a profound spatial inhomogeneity in the
vulnerability of cortical tissue to a reduced cerebral microcir-
culation.19,20 A major reduction in oxygen supply to tissues
remote from arteries can compromise oxidative
Fig 6. Changes in the amplitude of the somatosensory cortical evoked potential, cord dorsum potential, and electromyography in response
to haemorrhagic shock and the different treatments. * vs Sham (at least P<0.05); þ vs untreated Shock group (at least P<0.05). LR, lactated
Ringer’s solution.
Table 2 Peak latency of all potentials. ms, miliseconds; LR, lactated Ringer’ solution
Groups Peak Latency in ms and % of baseline at T120
Somatosensory evoked potential Cord dorsum potential Electromyography
Sham 1.46 (0.45) ms 0.54 (0.17) ms 0.31 (0.07) ms
104 (13%) 96 (4%) 99 (4%)
Shock 1.21 (0.49) ms 0.46 (0.15) ms 0.33 (0.08) ms
129 (31%) 95 (22%) 132 (55%)
3LR 1.85 (0.66) ms 0.53 (0.18) ms 0.31 (0.07) ms
101 (31%) 106 (20%) 85 (14%)
Terlipressin 1.72 (0.32) ms 0.58 (0.24) ms 0.28 (0.06) ms
119 (37%) 89 (14%) 138 (59%)
Terlipressin þ 1LR 1.55 (0.08) ms 0.39 (0.09) ms 0.28 (0.03) ms
85 (29%) 98 (7%) 128 (35%)
Terlipressin þ 2LR 1.70 (0.19) ms 0.37 (0.03) ms 0.24 (0.05) ms
91 (13%) 93 (8%) 101 (30%)
Terlipressin þ 3LR 1.51 (0.15) ms 0.47 (0.16) ms 0.24 (0.05) ms
91 (22%) 110 (28%) 129 (25%)
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phosphorylation and thus cellular ATP availability. This may
affect the ability to maintain neuronal excitability and sig-
nalling;22 in agreement, we also report a loss of cortical evoked
potential during shock. The status of bothmitochondrial23 and
neuronal24e26 function are known to have a close correlation
with prognosis after shock.
The failure to recover capillary perfusion by standard
aggressive fluid resuscitation is perhaps not unexpected, given
the failure of all therapies to achieve persistent restoration of
arterial pressure. This failure may result from the extravasa-
tion into interstitial tissues of large amounts of isotonic crys-
talloids,27 causing brain swelling and thus compressionwithin
the skull, diminishing the cerebral perfusion pressure
gradient.3,9 Arguably the most important consequence is
mitochondrial dysfunction, perhaps related to increased nitric
oxide production28 combined with reduced oxygen transport
to mitochondria. This is particularly pertinent in shock states,
as nitric oxide competes with oxygen for the same binding site
on mitochondrial Complex IV (cytochrome oxidase).28 Thus,
an increase in oxygenation does not necessarily signal a good
outcome, but perhaps a failure of oxygen utilization.
Small volume resuscitation has been proposed to avoid
tissue oedema resulting from aggressive fluid resuscitation.29
Indeed, animal models of haemorrhage have demonstrated
that terlipressin can restore cerebral perfusion pressure
without increasing intracranial pressure,17 namely conditions
required for an adequate microcirculation. An alternative
approach has been to provide perfusion by small-volume
isotonic fluid such as LR in combination with terlipressin,
which results in a more sustained improvement in arterial
pressure. The vasoconstrictor effect of terlipressin, which can
be given by a single bolus injection, makes it a simple and
practical treatment for use until hospital care is available.
Terlipressin improved survival in models of haemorrhagic
shock,14e16 as we observed in the present study. The main
adverse effect of terlipressin is the increase in systemic
vascular resistance that can further compromise both heart
function and local tissue blood flow.30 However, in a porcine
model of haemorrhagic shock, terlipressin was effective in
redistributing blood flow to recover cerebral perfusion pres-
sure and oxygenation without deleterious effects on systemic
perfusion.17 Accordingly, in human patients with
catecholamine-resistant shock, terlipressin has been suc-
cessfully used to improve cerebral perfusion pressure and
oxygenation in cases of septic shock,31 acute liver failure,32
and traumatic brain injury.33
A benefit of terlipressin on the brainwas the higher number
of perfused vessels when associated with LR in small volumes.
This indicates that terlipressin can reduce the volume of LR
necessary for resuscitation, thereby reducing the adverse ef-
fects of aggressive volume resuscitation, such as cerebral
expansion and compression. Studies using other vasopres-
sors, such as norepinephrine, did not report improved cerebral
perfusion pressure and oxygenation in models of haemor-
rhagic shock.7,34
Study limitations include the fact that the study was
focused on the effects of a vasopressor after haemorrhagic
shock, which resulted in the absence of groups treated with LR
in a volume of two and three times the volume of blood
removed to induce haemorrhagic shock. The absence of cor-
relation between vessel perfusion and tissue oxygenation
could be attributed to the fact that the method used to assess
vessel perfusion could not differentiate arteries from veins as
in the tissue oxygenation assessment. Finally, the data were
limited to 2 h after shock in an attempt to reflect a common
prehospital resuscitation regimen, and long-term outcomes
remain unknown.
The significant recovery of cerebral mitochondrial and
electrophysiological function by administration of terlipressin
and small volumes of LR was associated with restoration of a
near-normal density of perfused cortical vessels and cortical
mitochondrial function, at 2 h, with recovery of cortical-
evoked potentials. It is reasonable to expect that optimal
resuscitation therapy may avoid the complications of hae-
morrhagic shock encephalopathy. None of the other therapies
tested were as effective as the combination of terlipressin and
small volume LR.
Authors’ contributions
Designed the trial, obtained research funding, collected, ana-
lysed, and interpreted the data, drafted the manuscript, and
contributed substantially to its revision: K.K.I.
Contributed to experimental planning, to data analysis and
interpretation, and contributed substantially to its revision:
K.I.C.
Conceived the study, obtained research funding, and contrib-
uted substantially to its revision: L.M.S.M.
Contributed to provision of experimental chemicals, to anal-
ysis and interpretation of data, and contributed substantially
to its revision: D.B.P.
Provided senior advice on data analysis and interpretation and
contributed substantially to manuscript revision: A.D., M.S.,
M.R.D.
Obtained research funding, supervised the conduct of the trial
and data collection, provided senior advice to study design,
data analysis, and interpretation, and contributed substan-
tially to its revision: K.J.S.
Responsible for archiving the study files: K.K.I.
Read and approved the final manuscript: all authors.
Declaration of interest
The authors have no conflict of interest with any people or
organization that could inappropriately influence this work.
No potential competing interest is declared. D.P. is a stake-
holder of Luscel Biosciences which provided the oxygen-sen-
sitive microbeads for this study.
Funding
UK Multiple Sclerosis Society, the National Multiple Sclerosis
Society (USA), Coordenac¸~ao de Aperfeic¸oamento de Pessoal de
Nı´vel Superior (CAPES Ciencia sem Fronteiras #1064/61-24),
Fundac¸~ao de Amparo a Pesquisa do Estado de S~ao Paulo
(FAPESP #2011/14386-2), and Science Foundation Ireland (12/
RC/2276).
References
1. Kauvar DS, Lefering R, Wade CE. Impact of hemorrhage on
trauma outcome: an overview of epidemiology, clinical
presentations, and therapeutic considerations. J Trauma
2006; 60: S3e11
2. Gutierrez G, Reines HD, Wulf-Gutierrez ME. Clinical re-
view: hemorrhagic shock. Crit Care 2004; 8: 373e81
3. Cavus E, Meybohm P, Doerges V, et al. Cerebral effects
of three resuscitation protocols in uncontrolled
Small-volume resuscitation with terlipressin - 9
haemorrhagic shock: a randomised controlled experi-
mental study. Resuscitation 2009; 80: 567e72
4. Vincent JL, De Backer D. Circulatory shock. N Engl J Med
2013; 369: 1726e34
5. Taccone FS, De Backer D. Is cerebral microcirculation
really preserved in shock states? Crit Care Med 2010; 38:
1008e9
6. Meybohm P, Cavus E, Bein B, et al. Cerebral metabolism
assessed with microdialysis in uncontrolled hemorrhagic
shock after penetrating liver trauma. Anesth Analg 2006;
103: 948e54
7. Meybohm P, Cavus E, Bein B, et al. Neurochemical moni-
toring using intracerebral microdialysis during systemic
haemorrhage. Acta Neurochir (Wien) 2007; 149: 691e8
8. Anwar M, Agarwal R, Rashduni D, Weiss HR. Effects of
hemorrhagic hypotension on cerebral blood flow and
perfused capillaries in newborn pigs. Can J Physiol Phar-
macol 1996; 74: 157e62
9. Ida KKML, Otsuki DA, Chisholm KI, et al. Confocal imaging
of impaired mitochondrial function in the cerebral cortex
of rats during haemorrhagic shock in vivo. Intensive Care
Med Exp 2014; 2(Suppl 1). O9
10. Guven H, Amanvermez R, Malazgirt Z, et al. Moderate
hypothermia prevents brain stem oxidative stress injury
after hemorrhagic shock. J Trauma 2002; 53: 66e72
11. Meybohm P, Hoffmann G, Renner J, et al. Measurement of
blood flow index during antegrade selective cerebral
perfusion with near-infrared spectroscopy in newborn
piglets. Anesth Analg 2008; 106: 795e803
12. Urbano J, Lopez-Herce J, Solana MJ, Del Castillo J,
Botran M, Bellon JM. Comparison of normal saline, hy-
pertonic saline and hypertonic saline colloid resuscitation
fluids in an infant animal model of hypovolemic shock.
Resuscitation 2012; 83: 1159e65
13. Meybohm P, Cavus E, Bein B, et al. Small volume resus-
citation: a randomized controlled trial with either
norepinephrine or vasopressin during severe hemorrhage.
J Trauma 2007; 62: 640e6
14. Bayram B, Hocaoglu N, Atilla R, Kalkan S. Effects of terli-
pressin in a rat model of severe uncontrolled hemorrhage
via liver injury. Am J Emerg Med 2012; 30: 1176e82
15. Lee CC, Lee MT, Chang SS, et al. A comparison of vaso-
pressin, terlipressin, and lactated ringers for resuscitation
of uncontrolled hemorrhagic shock in an animal model.
PLoS One 2014; 9, e95821
16. Cossu AP, Mura P, De Giudici LM, et al. Vasopressin in
hemorrhagic shock: a systematic review and meta-
analysis of randomized animal trials. Biomed Res Int 2014;
2014, 421291
17. Ida KK, Otsuki DA, Sasaki AT, et al. Effects of terlipressin
as early treatment for protection of brain in a model of
haemorrhagic shock. Crit Care 2015; 19: 107
18. Dyson A, Stidwill R, Taylor V, Singer M. The impact of
inspired oxygen concentration on tissue oxygenation
during progressive haemorrhage. Intensive Care Med 2009;
35: 1783e91
19. Chisholm KI, Ida KK, Davies AL, et al. In vivo imaging of
flavoprotein fluorescence during hypoxia reveals the
importance of direct arterial oxygen supply to cerebral
cortex tissue. Adv Exp Med Biol 2016; 876: 233e9
20. Chisholm KI, Ida KK, Davies AL, et al. Hypothermia pro-
tects brain mitochondrial function from hypoxemia in a
murine model of sepsis. J Cereb Blood Flow Metab 2015; 36:
1955e64
21. Lee HB, Blaufox MD. Blood volume in the rat. J Nucl Med
1985; 26: 72e6
22. Erecinska M, Silver IA. Tissue oxygen tension and brain
sensitivity to hypoxia. Resp Physiol 2001; 128: 263e76
23. Fullerton JN, Singer M. Organ failure in the ICU: cellular
alterations. Semin Respir Crit Care Med 2011; 32: 581e6
24. Gregory PC, Mcgeorge AP, Fitch W, Graham DI,
MacKenzie ET, Harper AM. Effects of hemorrhagic hypo-
tension on the cerebral-circulation .2. electrocortical
function. Stroke 1979; 10: 719e23
25. Meldrum BS, Brierley JB. Brain damage in the rhesus
monkey resulting from profound arterial hypotension. II.
Changes in the spontaneous and evoked electrical activity
of the neocortex. Brain Res 1969; 13: 101e18
26. Graham DI, Fitch W, MacKenzie ET, Harper AM. Effects of
hemorrhagic hypotension on the cerebral circulation. III.
Neuropathology. Stroke 1979; 10: 724e7
27. Cotton BA, Guy JS, Morris Jr JA, Abumrad NN. The cellular,
metabolic, and systemic consequences of aggressive fluid
resuscitation strategies. Shock 2006; 26: 115e21
28. Umbrello M, Dyson A, Feelisch M, Singer M. The key role
of nitric oxide in hypoxia: hypoxic vasodilation and en-
ergy supply-demand matching. Antioxid Redox Signal 2013;
19: 1690e710
29. Tan PG, Cincotta M, Clavisi O, et al. Review article: pre-
hospital fluid management in traumatic brain injury.
Emerg Med Austr 2011; 23: 665e76
30. Beloncle F, Meziani F, Lerolle N, Radermacher P, Asfar P.
Does vasopressor therapy have an indication in hemor-
rhagic shock? Ann Intensive Care 2013; 3: 13e9
31. O’Brien A, Clapp L, Singer M. Terlipressin for
norepinephrine-resistant septic shock. Lancet 2002; 359:
1209e10
32. Eefsen M, Dethloff T, Frederiksen HJ, Hauerberg J,
Hansen BA, Larsen FS. Comparison of terlipressin and
noradrenalin on cerebral perfusion, intracranial pressure
and cerebral extracellular concentrations of lactate and
pyruvate in patients with acute liver failure in need of
inotropic support. J Hepatol 2007; 47: 381e6
33. Salluh JI, Martins GA, Santino MS, Arau´jo LV, Freitas GG,
Verdeal JC. Early use of terlipressin in catecholamine-
resistant shock improves cerebral perfusion pressure in
severe traumatic brain injury. Acta Anaesthesiol Scand 2007;
51: 505e8
34. Cavus E, Meybohm P, Dorges V, et al. Regional and local
brainoxygenationduringhemorrhagic shock: aprospective
experimental study on the effects of small-volume resus-
citation with norepinephrine. J Trauma 2008; 64: 641e8
Handling editor: H.F. Galley
10 - Ida et al.
